Back to search

University of Glasgow

Length polymorphisms in the hypervariable region-1 of hepatitis C virus E2: a novel regulator of viral entry and neutralisation

Abstract

dc:description.abstract

Currently 50 million people globally are living with Hepatitis C Virus (HCV). Whilst direct-acting antivirals offer a cure, there is no vaccine for HCV. One major barrier to the development of an effective HCV vaccine is the lack of mechanistic understanding of E1E2, the HCV viral entry proteins. Of particular importance for vaccine design is the Hypervariable Region-1 (HVR-1) of the E2 glycoprotein. HVR-1 is an intrinsically disordered tail which mediates entry and immune evasion through an unknown mechanism. Through state-of-the-art machine learning-enabled protein structure prediction, bioinformatic analysis, and in vitro experiments, we investigated how length polymorphisms in the HVR- 1 contribute to phenotype. We analysed 30,289 sequences covering >25 % of the E2 protein. To examine distribution of length polymorphisms across HCV genotypes, 9,103 unique HVR-1 sequences were extracted from this dataset and assessed. To evaluate HVR-1 conformation, we modelled 105 E2 proteins, and 96 E1E2 protein complexes using different protein structure prediction software platforms. To investigate how length polymorphisms in the HVR-1 affect virus phenotype, we cloned HVR- 1s of varying length into the prototypical J6 HCV to produce HCV pseudoparticles (HCVpp). We evaluated the infectivity, receptor dependency, and antibody sensitivity of this panel of HCVpp. Moreover, we produced sE2 proteins with the same length polymorphisms in the HVR-1 and interrogated their ability to bind SR-B1. This study found that the HVR-1 is predicted to be positioned in distinct conformations, length polymorphisms are common across all HCV genotypes, and length polymorphisms can modulate infectivity, receptor dependency, and neutralisation. Additionally, the sE2 experiments demonstrated that SR-B1 dependency and SR-B1 binding are uncoupled. These data allowed us to pull apart some of the molecular mechanism of the HVR-1. Altogether, this work suggests that the ability of the HVR-1 to adopt certain conformational states may correlate with phenotype. Moreover, length polymorphisms represent one way for HCV to fine tune the function of the HVR-1.

Degree

thesis:*
Level dc:type.qualificationlevel
PhD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Devlin, Stephen

Subjects

dc:subject × 1

Rights

Language dc:language
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Devlin, Stephen. Length polymorphisms in the hypervariable region-1 of hepatitis C virus E2: a novel regulator of viral entry and neutralisation. PhD thesis, University of Glasgow, 2026. https://doi.org/10.5525/gla.thesis.86281